Načítá se...
Pimavanserin for the treatment of psychosis in Alzheimer’s disease: A literature review
BACKGROUND: Alzheimer’s disease (AD) is among the most prevalent forms of dementia in the world and neuropathological studies suggest similar high prevalence of mixed (AD + vascular) dementias. Approximately 25%-50% of individuals with AD develop psychosis sometime during their illness. The presence...
Uloženo v:
| Vydáno v: | World J Psychiatry |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7418577/ https://ncbi.nlm.nih.gov/pubmed/32844093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5498/wjp.v10.i7.162 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|